Cargando…

Liver-specific agents for contrast-enhanced MRI: role in oncological imaging

Liver-specific magnetic resonance (MR) contrast agents are increasingly used in evaluation of the liver. They are effective in detection and morphological characterization of lesions, and can be useful for evaluation of biliary tree anatomy and liver function. The typical appearances and imaging pit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thian, Yee Liang, Riddell, Angela M., Koh, Dow-Mu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	e-Med 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893895/ https://www.ncbi.nlm.nih.gov/pubmed/24434892 http://dx.doi.org/10.1102/1470-7330.2013.0050

Ejemplares similares

Liver-specific contrast agents
por: Koh, Dow-Mu
Publicado: (2012)

Contrast-Enhanced CT Density Predicts Response to Sunitinib Therapy in Metastatic Renal Cell Carcinoma Patients
por: Matoori, Simon, et al.
Publicado: (2017)

The role of MRI using liver-specific contrast agent in the assessment of focal liver lesion
por: D'Ippolito, Giuseppe
Publicado: (2014)

Advanced Fusion Imaging and Contrast-Enhanced Imaging (CT/MRI–CEUS) in Oncology
por: Schwarze, Vincent, et al.
Publicado: (2020)

Glycosaminoglycans and Contrast Agents: The Role of Hyaluronic Acid as MRI Contrast Enhancer
por: Ponsiglione, Alfonso Maria, et al.
Publicado: (2020)

Small liver lesions in oncologic patients: characterization with CT, MRI and contrast-enhanced US
por: Morana, Giovanni, et al.
Publicado: (2008)

Use of contrast agents in oncological imaging: magnetic resonance imaging
por: Morana, Giovanni, et al.
Publicado: (2013)

Towards Enhanced MRI Performance of Tumor-Specific Dimeric Phenylboronic Contrast Agents
por: Martinelli, Jonathan, et al.
Publicado: (2021)

Comparison of a coaxial versus non-coaxial liver biopsy technique in an oncological setting: diagnostic yield, complications and seeding risk
por: Fotiadis, Nicos, et al.
Publicado: (2020)

Clinical Evaluation of an Abbreviated Contrast-Enhanced Whole-Body MRI for Oncologic Follow-Up Imaging
por: Herrmann, Judith, et al.
Publicado: (2021)

Inter-observer agreement of baseline whole body MRI in multiple myeloma
por: Croft, James, et al.
Publicado: (2020)

A robust MRI contrast agent for specific display of the interstitial stream
por: Zhou, Xiaohan, et al.
Publicado: (2023)

ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents
por: Neri, E., et al.
Publicado: (2015)

Contrast Enhancement in MRI Using Combined Double Action Contrast Agents and Image Post-Processing in the Breast Cancer Model
por: MacDonald, David, et al.
Publicado: (2023)

Contrast agents for hepatic MRI
por: Morana, Giovanni, et al.
Publicado: (2007)

MRI Contrast Agents in Glycobiology
por: Geraldes, Carlos F. G. C., et al.
Publicado: (2022)

Contrast agents in dynamic contrast-enhanced magnetic resonance imaging
por: Yan, Yuling, et al.
Publicado: (2017)

A novel nitroreductase-enhanced MRI contrast agent and its potential application in bacterial imaging
por: Liu, Yun, et al.
Publicado: (2018)

Update on the Use of PET/MRI Contrast Agents and Tracers in Brain Oncology: A Systematic Review
por: Smeraldo, Alessio, et al.
Publicado: (2022)

Increase in lesion enhancement on gadoxetic acid enhanced MRI is associated with complete response to neoadjuvant chemotherapy in colorectal liver metastases
por: Islam, S, et al.
Publicado: (2015)

MR Imaging in Patients with Suspected Liver Metastases: Value of Liver-Specific Contrast Agent Gadoxetic Acid
por: Lee, Kyung Hee, et al.
Publicado: (2013)

Demonstration of the reproducibility of free-breathing diffusion-weighted MRI and dynamic contrast enhanced MRI in children with solid tumours: a pilot study
por: Miyazaki, Keiko, et al.
Publicado: (2015)

A Peptide Targeted Contrast Agent Specific to Fibrin-Fibronectin Complexes for Cancer Molecular Imaging with MRI
por: Ye, Furong, et al.
Publicado: (2008)

A Peptide Targeted Contrast Agent Specific to Fibrin−Fibronectin Complexes for Cancer Molecular Imaging with MRI
por: Ye, Furong, et al.
Publicado: (2009)

Contrast-enhanced ultrasound in oncology
por: Madsen, H.H.T., et al.
Publicado: (2011)

Impact of contrast agent injection duration on dynamic contrast‐enhanced MRI quantification in prostate cancer
por: Klawer, Edzo M.E., et al.
Publicado: (2018)

Quasi-Cubic Magnetite/Silica Core-Shell Nanoparticles as Enhanced MRI Contrast Agents for Cancer Imaging
por: Campbell, Jos L., et al.
Publicado: (2011)

Fluorine-19 MRI Contrast Agents for Cell Tracking and Lung Imaging
por: Fox, Matthew S., et al.
Publicado: (2016)

MRI Contrast Agents for Pharmacological Research
por: Terreno, Enzo, et al.
Publicado: (2015)

Magnetic Nanomaterials as Contrast Agents for MRI
por: Caspani, Sofia, et al.
Publicado: (2020)

Magnetic Nanoparticles as MRI Contrast Agents
por: Avasthi, Ashish, et al.
Publicado: (2020)

How to develop a meaningful radiomic signature for clinical use in oncologic patients
por: Papanikolaou, Nikolaos, et al.
Publicado: (2020)

Optimisation of b-values for the accurate estimation of the apparent diffusion coefficient (ADC) in whole-body diffusion-weighted MRI in patients with metastatic melanoma
por: Knill, Annemarie K., et al.
Publicado: (2022)

Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agents
por: Chaudhary, Rajneesh, et al.
Publicado: (2016)

Tumor-Attentive Segmentation-Guided GAN for Synthesizing Breast Contrast-Enhanced MRI Without Contrast Agents
Publicado: (2022)

Imaging tumour response: beyond RECIST
por: Koh, Dow-Mu
Publicado: (2014)

Comparison of gadolinium-based contrast agents for MR cholangiography in saline, blood and bile: a phantom study
por: Froehlich, Johannes M., et al.
Publicado: (2023)

Comparison of Dynamic and Liver-Specific Gadoxetic Acid Contrast-Enhanced MRI versus Apparent Diffusion Coefficients
por: Morelli, John N., et al.
Publicado: (2013)

Advances in Medical Imaging: Aptamer- and Peptide-Targeted MRI and CT Contrast Agents
por: Koudrina, Anna, et al.
Publicado: (2020)

Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy
por: Cai, Xiaoxia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2dqu3ovkqldu41j7o1jq2r2e11